Heritage Financial (HFWA)


Market Price (8/1/2026): $29.72 | Market Cap: $1.1 BilSector: Financials | Industry: Regional Banks

Heritage Financial (HFWA)


Market Price (8/1/2026): $29.72
Market Cap: $1.1 Bil
Sector: Financials
Industry: Regional Banks

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 9.1%, Dividend Yield is 2.8%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 4.8%, FCF Yield is 7.0%

Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -99%

Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 34%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 30%

Low stock price volatility
Vol 12M is 28%

Megatrend and thematic drivers
Megatrends include Fintech & Digital Payments. Themes include Online Banking & Lending, Digital Payments, and Wealth Management Technology.

Trading close to highs
Dist 52W High is -4.9%, Dist 3Y High is -4.9%

Key risks
HFWA key risks include [1] concentrated credit risk from its commercial real estate loan portfolio (60.8%), Show more.

0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 9.1%, Dividend Yield is 2.8%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 4.8%, FCF Yield is 7.0%
1 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -99%
2 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 34%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 30%
3 Low stock price volatility
Vol 12M is 28%
4 Megatrend and thematic drivers
Megatrends include Fintech & Digital Payments. Themes include Online Banking & Lending, Digital Payments, and Wealth Management Technology.
5 Trading close to highs
Dist 52W High is -4.9%, Dist 3Y High is -4.9%
6 Key risks
HFWA key risks include [1] concentrated credit risk from its commercial real estate loan portfolio (60.8%), Show more.

HFWA in ETFs

Weight = HFWA's share of each fund

VTI0.00%
ITOT0.00%
IWM0.04%
IJR0.07%
KRE0.25%
SLYV0.14%
IJS0.14%
VIOV0.13%
+7 more covered ETFs

Valuation & Metrics

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Updated on 7/1/2026

Heritage Financial (HFWA) stock has gained about 10% since 4/30/2026 because of the following key factors:

1. Heritage Financial's strong fiscal Q1 2026 earnings, reported on April 23, 2026, exceeded analyst expectations for both earnings per share (EPS) and revenue, setting a positive tone for the period. The company reported an actual EPS of $0.48, significantly beating the consensus estimate of $0.31 or $0.4641. Additionally, revenue reached $99.37 million, surpassing the estimated $80.49 million.

2. The company demonstrated robust performance in fiscal Q2 2026, despite a slight revenue miss, with a significant EPS beat and expanding net interest margin. For the quarter reported on July 23, 2026, Heritage Financial posted an EPS of $0.57, outperforming analyst consensus estimates ranging from $0.44 to $0.47 per share. The net interest margin expanded by 3 basis points to 3.99%, driven by asset repricing and merger benefits. Furthermore, loan originations surged 104% sequentially to $339 million, with total loan balances increasing by $26 million. Management projects annualized loan growth in the mid-single-digit range for the upcoming quarters.

Show more
Updated on 7/1/2026

Heritage Financial (HFWA) stock has gained about 10% since 4/30/2026 because of the following key factors:

1. Heritage Financial's strong fiscal Q1 2026 earnings, reported on April 23, 2026, exceeded analyst expectations for both earnings per share (EPS) and revenue, setting a positive tone for the period. The company reported an actual EPS of $0.48, significantly beating the consensus estimate of $0.31 or $0.4641. Additionally, revenue reached $99.37 million, surpassing the estimated $80.49 million.

2. The company demonstrated robust performance in fiscal Q2 2026, despite a slight revenue miss, with a significant EPS beat and expanding net interest margin. For the quarter reported on July 23, 2026, Heritage Financial posted an EPS of $0.57, outperforming analyst consensus estimates ranging from $0.44 to $0.47 per share. The net interest margin expanded by 3 basis points to 3.99%, driven by asset repricing and merger benefits. Furthermore, loan originations surged 104% sequentially to $339 million, with total loan balances increasing by $26 million. Management projects annualized loan growth in the mid-single-digit range for the upcoming quarters.

3. Heritage Financial benefited from a broader positive trend in the regional banking sector, which experienced strong earnings growth and net interest margin expansion. Through July 29, the S&P Regional Bank ETF returned 18.9% year-to-date, outperforming the broader market. This sector-wide improvement was driven by factors such as a positively sloped yield curve, repricing of assets, and lower funding costs, contributing to overall earnings growth and stable credit quality across regional banks.

4. Several analyst firms upgraded their ratings and raised price targets for Heritage Financial, indicating increased confidence in the company's future prospects. Notably, Wall Street Zen upgraded HFWA from "sell" to "hold" on May 16, and Zacks Research upgraded it from "strong sell" to "hold" on June 26. Additionally, Keefe, Bruyette & Woods increased its price target from $31.00 to $32.00, while DA Davidson and Piper Sandler both raised their price targets to $34.00.

Show less
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The 9.0% change in HFWA stock from 4/30/2026 to 7/31/2026 was primarily driven by a 15.5% change in the company's P/E Multiple.
(LTM values as of)43020267312026Change
Stock Price ($)27.2829.739.0%
Change Contribution By: 
Total Revenues ($ Mil)2462668.3%
Net Income Margin (%)27.4%27.2%-0.7%
P/E Multiple13.715.815.5%
Shares Outstanding (Mil)3439-12.2%
Cumulative Contribution9.0%

LTM = Last Twelve Months as of date shown

Market Drivers

4/30/2026 to 7/31/2026
ReturnCorrelation
HFWA9.0% 
Market (SPY)3.9%9.4%
Sector (XLF)9.2%45.4%

Fundamental Drivers

The 16.2% change in HFWA stock from 1/31/2026 to 7/31/2026 was primarily driven by a 12.7% change in the company's Net Income Margin (%).
(LTM values as of)13120267312026Change
Stock Price ($)25.5829.7316.2%
Change Contribution By: 
Total Revenues ($ Mil)23726612.5%
Net Income Margin (%)24.2%27.2%12.7%
P/E Multiple15.215.84.4%
Shares Outstanding (Mil)3439-12.2%
Cumulative Contribution16.2%

LTM = Last Twelve Months as of date shown

Market Drivers

1/31/2026 to 7/31/2026
ReturnCorrelation
HFWA16.2% 
Market (SPY)8.3%26.1%
Sector (XLF)7.1%54.2%

Fundamental Drivers

The 37.2% change in HFWA stock from 7/31/2025 to 7/31/2026 was primarily driven by a 19.6% change in the company's Net Income Margin (%).
(LTM values as of)73120257312026Change
Stock Price ($)21.6729.7337.2%
Change Contribution By: 
Total Revenues ($ Mil)22626618.0%
Net Income Margin (%)22.8%27.2%19.6%
P/E Multiple14.315.810.6%
Shares Outstanding (Mil)3439-12.1%
Cumulative Contribution37.2%

LTM = Last Twelve Months as of date shown

Market Drivers

7/31/2025 to 7/31/2026
ReturnCorrelation
HFWA37.2% 
Market (SPY)19.2%30.9%
Sector (XLF)10.0%54.9%

Fundamental Drivers

The 80.4% change in HFWA stock from 7/31/2023 to 7/31/2026 was primarily driven by a 126.2% change in the company's P/E Multiple.
(LTM values as of)73120237312026Change
Stock Price ($)16.4829.7380.4%
Change Contribution By: 
Total Revenues ($ Mil)2622661.9%
Net Income Margin (%)31.6%27.2%-13.7%
P/E Multiple7.015.8126.2%
Shares Outstanding (Mil)3539-9.2%
Cumulative Contribution80.4%

LTM = Last Twelve Months as of date shown

Market Drivers

7/31/2023 to 7/31/2026
ReturnCorrelation
HFWA80.4% 
Market (SPY)68.9%37.9%
Sector (XLF)68.4%59.6%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
HFWA Return8%29%-27%20%1%27%56%
Peers Return18%-1%-9%15%3%14%45%
S&P 500 Return27%-19%24%23%16%9%98%

Monthly Win Rates [3]
HFWA Win Rate58%50%33%42%42%57% 
Peers Win Rate62%47%43%53%50%57% 
S&P 500 Win Rate75%42%67%75%67%43% 

Max Drawdowns [4]
HFWA Max Drawdown-26%-13%-49%-20%-19%-13% 
Peers Max Drawdown-23%-23%-41%-22%-25%-15% 
S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: COLB, BANR, WAFD, GBCI, FIBK.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 7/31/2026 (YTD)

How Low Can It Go

EventHFWAS&P 500
2025 US Tariff Shock
  % Loss-13.9%-18.8%
  % Gain to Breakeven16.1%23.1%
  Time to Breakeven31 days79 days
Summer-Fall 2023 Five Percent Yield Shock
  % Loss-11.5%-9.5%
  % Gain to Breakeven13.0%10.5%
  Time to Breakeven20 days24 days
2023 SVB Regional Banking Crisis
  % Loss-46.4%-6.7%
  % Gain to Breakeven86.7%7.1%
  Time to Breakeven544 days31 days
2020 COVID-19 Crash
  % Loss-34.4%-33.7%
  % Gain to Breakeven52.5%50.9%
  Time to Breakeven273 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-19.5%-19.2%
  % Gain to Breakeven24.2%23.8%
  Time to Breakeven1395 days105 days
2011 US Debt Ceiling Crisis & European Contagion
  % Loss-19.4%-17.9%
  % Gain to Breakeven24.0%21.8%
  Time to Breakeven20 days123 days

Compare to COLB, BANR, WAFD, GBCI, FIBK

In The Past

Heritage Financial's stock fell -13.9% during the 2025 US Tariff Shock. Such a loss loss requires a 16.1% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

EventHFWAS&P 500
2023 SVB Regional Banking Crisis
  % Loss-46.4%-6.7%
  % Gain to Breakeven86.7%7.1%
  Time to Breakeven544 days31 days
2020 COVID-19 Crash
  % Loss-34.4%-33.7%
  % Gain to Breakeven52.5%50.9%
  Time to Breakeven273 days140 days
2008-2009 Global Financial Crisis
  % Loss-51.9%-53.4%
  % Gain to Breakeven108.0%114.4%
  Time to Breakeven1719 days1085 days

Compare to COLB, BANR, WAFD, GBCI, FIBK

In The Past

Heritage Financial's stock fell -13.9% during the 2025 US Tariff Shock. Such a loss loss requires a 16.1% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Heritage Financial (HFWA)

Heritage Financial Corporation (HFWA) operates as the bank holding company for Heritage Bank, serving small and medium-sized businesses and individuals primarily across Washington and Oregon. The company's core business involves traditional banking services, focused on attracting various deposit products and originating a diverse portfolio of loans within its regional market. This structure allows it to function as a community-oriented financial institution.

The company provides a wide range of financial products, including various deposit accounts such as noninterest and interest-bearing demand deposits, money market accounts, savings accounts, personal checking accounts, and certificates of deposit. On the lending side, Heritage Bank offers commercial and industrial loans, a full spectrum of commercial real estate loans (including owner-occupied, non-owner occupied, construction, and land development), one-to-four family residential loans, and consumer loans. Additionally, it offers commercial business loans, lines of credit, and equipment financing, alongside loans guaranteed by the U.S. Small Business Administration (SBA).

Heritage Financial targets a broad customer base, with its commercial lending reaching industries such as real estate and rental and leasing, healthcare, accommodation and food services, retail trade, and construction. Beyond its primary deposit and lending activities, the company also offers specialized trust services and provides objective financial advice. Through its network of banking offices, Heritage Bank aims to be a comprehensive financial partner for its clientele in the Pacific Northwest.

AI Analysis | Feedback

Here are 1-3 brief analogies for Heritage Financial (HFWA):

  • Wells Fargo for the Pacific Northwest.
  • A regional U.S. Bank serving Washington and Oregon.

AI Analysis | Feedback

  • Deposit Services: Accepts a range of deposit products including checking, savings, money market, and certificates of deposit.
  • Commercial Loans: Provides various financing options to businesses, such as commercial and industrial loans, commercial real estate loans, lines of credit, and equipment financing.
  • Residential Real Estate Loans: Offers loans for one-to-four family residential properties.
  • Consumer Loans: Provides various loan products directly to individual customers.
  • SBA Guaranteed Loans: Originates loans guaranteed by the U.S. Small Business Administration for business financing.
  • Trust Services: Delivers fiduciary services for managing assets and providing objective advice.

AI Analysis | Feedback

Major Customers of Heritage Financial (HFWA)

Heritage Financial (HFWA), as a bank holding company for Heritage Bank, primarily serves a diverse customer base rather than a few specific major companies. Its customers can be categorized into two main segments:

  • Small and Medium-Sized Businesses: Heritage Bank provides a comprehensive range of financial services to small and medium-sized businesses. This includes commercial and industrial loans, owner-occupied and non-owner occupied commercial real estate loans, real estate construction and land development loans, commercial business loans (including those guaranteed by the U.S. Small Business Administration), lines of credit, and term equipment financing. These businesses operate across various industries such as real estate and rental and leasing, healthcare, accommodation and food services, retail trade, and construction. The bank also offers various deposit products to these businesses.
  • Individuals/Consumers: The company serves individuals for their personal banking needs. This includes a variety of deposit products like noninterest demand deposits, interest-bearing demand deposits, money market accounts, savings accounts, personal checking accounts, and certificates of deposit. For lending, individuals can access one-to-four family residential loans and other consumer loans. The bank also provides trust services and objective financial advice to individuals.

AI Analysis | Feedback

null

AI Analysis | Feedback

Bryan D. McDonald, President and Chief Executive Officer
Mr. McDonald was promoted to President and Chief Executive Officer of Heritage Financial Corporation effective May 6, 2025. He joined Heritage in May 2014 as Executive Vice President and Chief Lending Officer, following the merger with Whidbey Island Bank. Prior to that, he served as President and Chief Executive Officer of Whidbey Island Bank from January 2012 to May 2014. His career in banking spans over 30 years with extensive executive leadership experience in various areas including sales, credit, operations, commercial banking, and residential real estate. Donald J. Hinson, Executive Vice President and Chief Financial Officer
Mr. Hinson serves as the Executive Vice President and Chief Financial Officer, a position to which he was promoted in September 2012. He joined Heritage Financial Corporation in 2005 as Vice President and Controller. Before joining the company, Mr. Hinson worked in the banking audit practice of local and national accounting firms, including Knight, Vale and Gregory and RSM McGladrey, from 1994 to 2005. He is a licensed Certified Public Accountant. Nicholas M. Bley, Executive Vice President and Chief Operations Officer
Mr. Bley is the Executive Vice President of Heritage Financial Corporation and the Executive Vice President and Chief Operations Officer of Heritage Bank. He joined the company in October 2024. Previously, Mr. Bley held various roles with JPMorgan Chase & Co., most recently as Managing Director and Commercial Real Estate Senior Regional Sales Manager. He also serves on the Board of Trustees of the Seattle Chamber of Commerce. Anthony Chalfant, Executive Vice President and Chief Credit Officer
Mr. Chalfant holds the position of Executive Vice President and Chief Credit Officer for both Heritage Financial Corporation and Heritage Bank. Kaylene M. Lahn, Senior Vice President, Corporate Governance Officer and Corporate Secretary
Ms. Lahn is the Senior Vice President, Corporate Governance Officer and Corporate Secretary, appointed to her Senior Vice President and Corporate Secretary role in 2008. Her tenure at Heritage includes serving as the Internal Control Officer from 2005 to 2008, the Controller for Heritage Bank from 2001 to 2005, and a Senior Staff Accountant from 1999 to 2001. Prior to Heritage, she worked for the public accounting firm of Knight, Vale and Gregory from 1996 to 1999.

AI Analysis | Feedback

Here are the key risks to Heritage Financial (HFWA):
  1. Credit Risk, particularly within Commercial Real Estate: Heritage Financial's loan portfolio includes a significant allocation to commercial real estate, including owner-occupied and non-owner-occupied properties, and commercial and industrial loans. There are concerns regarding rising non-performing loans and an increase in substandard loans. Specifically, a substantial portion of the company's gross loans is exposed to commercial real estate, particularly office properties, which are vulnerable to the effects of rising interest rates, increased operating costs due to inflation, and reduced demand from cultural shifts such as work-from-home models. A potential recession could further impact these properties, leading to decreased valuations and putting the associated debt at risk.
  2. Interest Rate Risk and Net Interest Margin Fluctuations: As a bank, Heritage Financial's profitability is highly sensitive to changes in interest rates. While recent reports indicate an improving net interest margin and lower cost of deposits, historical data suggests "continued pressure on margins". Fluctuations in interest rates can impact the value of the company's loan book, the cost of its deposits, and overall net interest income, affecting its financial performance.
  3. Cybersecurity and Information Technology Systems Risk: Heritage Financial faces risks from "disruptions, security breaches, insider fraud, cybersecurity incidents or other adverse events, failures or interruptions in, or attacks on, our information technology systems or on the third-party vendors who perform critical processing functions for our business, including sophisticated attacks using artificial intelligence and similar tools". Such incidents could lead to financial losses, reputational damage, and regulatory penalties.

AI Analysis | Feedback

A clear emerging threat for Heritage Financial is the increasing prominence of digital-only banks (neobanks) and online lenders. These entities operate with significantly lower overhead due to the absence of physical branch networks, allowing them to offer more competitive rates, lower fees, and a more streamlined, mobile-first customer experience. This directly challenges Heritage Financial's ability to attract and retain depositors and loan customers, particularly individuals and small to medium-sized businesses seeking convenience and speed over traditional banking relationships. Examples include companies like Chime, Varo, and Ally Bank for consumer banking, and various online platforms specializing in small business loans.

Another clear emerging threat comes from large technology companies ("Big Tech") like Apple, Google, and Amazon, which are increasingly expanding into financial services. Leveraging their vast user bases, data analytics capabilities, and sophisticated technology platforms, these companies are offering services such as digital payments, credit products (e.g., Apple Card), and potentially more comprehensive banking-like features, either directly or in partnership with other financial institutions. This encroachment into traditional banking domains threatens to disintermediate Heritage Financial from its customers, particularly in transaction processing and consumer credit, by providing integrated, user-friendly alternatives.

AI Analysis | Feedback

Heritage Financial (HFWA) operates in Washington and Oregon, providing a range of financial services, including deposit products, various types of loans, and trust services.

Addressable Market Sizes for Main Products/Services:

  • Overall Banking Market (Total Assets):
    The total banking assets for Washington state were approximately $99.71 billion as of Q2 2025. For Oregon, total banking assets were about $77.85 billion as of Q4 2025. The combined total banking assets in Heritage Financial's operating region (Washington and Oregon) are approximately $177.56 billion.
  • Deposits:
    For Oregon and Clark County, Washington, the total deposits among the top listed banks were approximately $97.2 billion as of June 30, 2023. This figure represents a significant portion of the deposit market in those specific areas.
  • Commercial Real Estate (CRE) Loans:
    The commercial real estate market in Oregon generated an estimated $14 billion in annual transaction volume in 2026. While Washington's commercial real estate market is described as thriving, a specific market size for commercial real estate loans was not identified for the entire state.
  • Real Estate Loans & Collateralized Debt (Oregon):
    The market size of the Real Estate Loans & Collateralized Debt industry in Oregon is projected to be $2.2 billion in 2026. This industry encompasses various forms of real estate and collateralized lending.
  • Residential Home Sales Volume (Washington):
    The total dollar value of closed sales for residential homes in Washington state, within the Northwest Multiple Listing Service (NWMLS) coverage area, was approximately $5.17 billion in July 2025. An additional $517.3 million was recorded for condominiums in the same period, bringing the total to about $5.69 billion for July 2025.
  • Small Business Loans:
    In Oregon, new lending to businesses through loans of $1 million or less totaled $2.4 billion in 2023.
  • Trust Services:
    Washington state-chartered banks had $54.14 billion in total trust assets under management as of December 31, 2023.
  • Consumer Loans (Small-Dollar Credit):
    In Oregon, fintech companies and community banks facilitated over 1 million small-dollar loans totaling $2.6 billion. In 2024 alone, these members provided more than 103,000 loans worth over $416 million.

AI Analysis | Feedback

Heritage Financial (HFWA) is expected to experience future revenue growth over the next 2-3 years driven by several key factors:

  1. Strategic Mergers and Acquisitions (M&A): The completed merger with Olympic Bancorp, which integrated Kitsap Bank into Heritage's operations, is a significant driver for expanding its branch network, customer base, and market share, particularly in the Puget Sound region. Heritage Financial also has a long-term strategy to grow through potential M&A opportunities in the Pacific Northwest.
  2. Increased Loan Growth: Heritage Financial anticipates a return to historical loan growth levels in 2026, with expectations for low single-digit growth in Q1 accelerating to upper single digits by year-end. This renewed growth in its loan portfolio is expected as loan payoffs moderate, directly contributing to higher interest income.
  3. Net Interest Margin (NIM) Expansion: The company has seen improvements in its net interest margin, which reached 3.72% in Q4 2025, up from 3.36% in Q4 2024. Further expansion of the net interest margin, potentially reaching near 4% by year-end (referring to 2026), partly due to the Olympic Bancorp merger and expected decreases in deposit costs, is anticipated to enhance net interest income.
  4. Geographic Expansion and Digital Banking Investments: Heritage Financial's expansion into new markets, such as Spokane, Washington, with the addition of commercial banking teams, is aimed at broadening its customer reach. Concurrently, strategic investments in digital banking are expected to unlock value by expanding customer service capabilities and market presence across the Pacific Northwest.

AI Analysis | Feedback

Share Repurchases

  • In the fourth quarter of 2024, Heritage Financial made $4.4 million in common stock repurchases.
  • During the second quarter of 2025, the company repurchased 193,700 shares at a total cost of $4.5 million.
  • As of the end of the second quarter of 2025, there were 797,000 shares remaining available for repurchase under the current share repurchase plan.

Share Issuance

  • In January 2026, Heritage Financial's shareholders approved the issuance of common stock as part of its Merger Agreement with Olympic Bancorp, Inc.

Outbound Investments

  • In the fourth quarter of 2024, Heritage Financial sold $35.6 million of investment securities; the proceeds were used to fund higher-yielding loan growth.
  • Heritage Financial is acquiring Olympic Bancorp, Inc., including its subsidiary Kitsap Bank, with the acquisition expected to close around January 31, 2026, pending regulatory and shareholder approvals already received.

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

HFWACOLBBANRWAFDGBCIFIBKMedian
NameHeritage.Columbia.Banner WaFd Glacier .First In. 
Mkt Price29.7331.2770.4136.7749.2938.0237.40
Mkt Cap1.29.12.42.86.43.83.3
Rev LTM2662,4876637631,0871,054908
Op Inc LTM-------
FCF LTM801,061302217375253278
FCF 3Y Avg80838269278331336304
CFO LTM901,118310255410282296
CFO 3Y Avg86869281306374362334

Growth & Margins

HFWACOLBBANRWAFDGBCIFIBKMedian
NameHeritage.Columbia.Banner WaFd Glacier .First In. 
Rev Chg LTM18.0%27.8%7.3%3.9%30.0%4.9%12.7%
Rev Chg 3Y Avg1.5%23.3%1.1%1.2%8.5%-2.2%1.3%
Rev Chg Q35.3%37.9%6.0%10.1%38.1%-2.1%22.7%
QoQ Delta Rev Chg LTM8.3%8.1%1.4%2.4%8.2%-0.5%5.3%
Op Inc Chg LTM-------
Op Inc Chg 3Y Avg-------
Op Mgn LTM-------
Op Mgn 3Y Avg-------
QoQ Delta Op Mgn LTM-------
CFO/Rev LTM33.6%45.0%46.7%33.5%37.7%26.8%35.6%
CFO/Rev 3Y Avg36.4%39.8%44.8%42.1%42.2%35.5%41.0%
FCF/Rev LTM30.1%42.7%45.5%28.4%34.5%24.0%32.3%
FCF/Rev 3Y Avg33.7%38.4%42.8%38.3%37.1%33.0%37.7%

Valuation

HFWACOLBBANRWAFDGBCIFIBKMedian
NameHeritage.Columbia.Banner WaFd Glacier .First In. 
Mkt Cap1.29.12.42.86.43.83.3
P/S4.33.73.63.65.93.63.6
P/Op Inc-------
P/EBIT-------
P/E15.813.911.711.024.012.013.0
P/CFO12.88.17.710.915.613.311.9
Total Yield9.1%11.2%11.4%12.1%6.7%13.4%11.3%
Dividend Yield2.8%4.0%2.8%3.0%2.5%5.1%2.9%
FCF Yield 3Y Avg10.0%14.8%13.0%12.1%6.4%10.9%11.5%
D/E0.00.40.01.10.10.10.1
Net D/E-1.00.2-0.1-0.4-0.8-0.3-0.3

Returns

HFWACOLBBANRWAFDGBCIFIBKMedian
NameHeritage.Columbia.Banner WaFd Glacier .First In. 
1M Rtn-1.7%-3.8%3.8%-5.8%-6.0%-3.2%-3.5%
3M Rtn8.6%7.1%7.8%4.5%1.1%8.7%7.4%
6M Rtn16.2%8.9%15.7%14.5%-1.4%9.9%12.2%
12M Rtn37.2%38.3%17.1%30.6%15.6%39.7%33.9%
3Y Rtn80.8%69.7%63.0%33.0%66.7%62.6%64.8%
1M Excs Rtn-1.7%-3.9%3.7%-5.9%-6.1%-3.2%-3.6%
3M Excs Rtn5.1%3.1%2.2%0.8%-2.8%4.6%2.6%
6M Excs Rtn10.2%2.9%8.4%7.1%-7.4%0.4%5.0%
12M Excs Rtn18.3%20.1%-2.0%12.7%-5.0%22.9%15.5%
3Y Excs Rtn16.4%1.4%0.7%-35.0%-2.7%-6.3%-1.0%

Comparison Analyses

null

FDA Approved Drugs Data

Expand for More
Post-Approval Fwd Returns
FDA
App #
Brand
Name
Generic
Name
Dosage
Form
FDA
Approval
3M
Rtn
6M
Rtn
1Y
Rtn
2Y
Rtn
Total
Rtn
ANDA218896  TRANEXAMIC ACIDtranexamic acidsolution60220257.9%7.3%24.6%35.1%35.1%
ANDA217854  DOXYCYCLINE HYCLATEdoxycycline hyclateinjectable7232024-0.4%14.4%17.9%48.8%46.0%
ANDA216677  DOCETAXELdocetaxelinjectable2282024-2.7%29.3%42.7%57.6%79.0%
ANDA205950  TRIMETHOBENZAMIDE HYDROCHLORIDEtrimethobenzamide hydrochloridecapsule112120238.1%12.1%53.8%40.3%90.3%
ANDA216309  BACLOFENbaclofeninjectable8102023-9.0%0.6%19.4%33.3%81.4%
ANDA215829  VERAPAMIL HYDROCHLORIDEverapamil hydrochlorideinjectable3172022-6.0%6.6%-10.6%-22.4%37.6%
ANDA208058  LURASIDONE HYDROCHLORIDElurasidone hydrochloridetablet90420197.9%-5.4%-16.8%4.6%50.9%
ANDA211682  OXYBUTYNIN CHLORIDEoxybutynin chloridetablet5102019-11.0%-4.8%-37.4%0.5%26.1%
ANDA205136  MECLIZINE HYDROCHLORIDEmeclizine hydrochloridetablet2222019-9.1%-20.5%-15.8%-19.8%19.4%
ANDA204669  OCTREOTIDE ACETATEoctreotide acetateinjectable122720184.8%1.3%-0.1%-15.1%35.7%
...         
Collapse to Preview
Post-Approval Fwd Returns
FDA
App #
Brand
Name
Generic
Name
Dosage
Form
FDA
Approval
3M
Rtn
6M
Rtn
1Y
Rtn
2Y
Rtn
Total
Rtn
ANDA218896  TRANEXAMIC ACIDtranexamic acidsolution60220257.9%7.3%24.6%35.1%35.1%
ANDA217854  DOXYCYCLINE HYCLATEdoxycycline hyclateinjectable7232024-0.4%14.4%17.9%48.8%46.0%
ANDA216677  DOCETAXELdocetaxelinjectable2282024-2.7%29.3%42.7%57.6%79.0%
ANDA205950  TRIMETHOBENZAMIDE HYDROCHLORIDEtrimethobenzamide hydrochloridecapsule112120238.1%12.1%53.8%40.3%90.3%
ANDA216309  BACLOFENbaclofeninjectable8102023-9.0%0.6%19.4%33.3%81.4%
ANDA215829  VERAPAMIL HYDROCHLORIDEverapamil hydrochlorideinjectable3172022-6.0%6.6%-10.6%-22.4%37.6%
ANDA208058  LURASIDONE HYDROCHLORIDElurasidone hydrochloridetablet90420197.9%-5.4%-16.8%4.6%50.9%
ANDA211682  OXYBUTYNIN CHLORIDEoxybutynin chloridetablet5102019-11.0%-4.8%-37.4%0.5%26.1%
ANDA205136  MECLIZINE HYDROCHLORIDEmeclizine hydrochloridetablet2222019-9.1%-20.5%-15.8%-19.8%19.4%
ANDA204669  OCTREOTIDE ACETATEoctreotide acetateinjectable122720184.8%1.3%-0.1%-15.1%35.7%
ANDA203765  OCTREOTIDE ACETATEoctreotide acetateinjectable9072018-10.9%-14.8%-28.4%-39.1%8.5%
ANDA207035  ACETAMINOPHENacetaminophentablet, extended release531201812.3%9.7%-10.5%-37.3%24.0%
ANDA205210  DOXAZOSIN MESYLATEdoxazosin mesylatetablet21320187.9%21.9%10.6%-4.4%35.3%
ANDA207935  DUTASTERIDEdutasteridecapsule101320177.5%4.1%12.1%-7.1%36.1%
ANDA209171  AMANTADINE HYDROCHLORIDEamantadine hydrochloridecapsule61220173.0%21.4%31.7%19.2%58.0%
ANDA207880  DESMOPRESSIN ACETATEdesmopressin acetatetablet526201711.0%29.5%38.4%29.3%69.8%
ANDA205530  ACETAZOLAMIDEacetazolamidetablet1027201649.4%54.4%78.9%86.2%133.4%
ANDA205532  LITHIUM CARBONATElithium carbonatetablet, extended release929201647.8%42.5%71.2%108.4%135.3%
ANDA204945  TROSPIUM CHLORIDEtrospium chloridetablet830201624.5%38.1%45.6%105.0%126.3%
ANDA206975  BUPROPION HYDROCHLORIDEbupropion hydrochloridetablet819201627.1%43.1%49.6%107.8%132.1%
ANDA207433  DESIPRAMINE HYDROCHLORIDEdesipramine hydrochloridetablet50520160.9%6.9%51.6%90.9%145.5%
ANDA204582  BUSPIRONE HYDROCHLORIDEbuspirone hydrochloridetablet9182015-0.8%-2.3%0.3%56.3%133.5%
ANDA205126  CARISOPRODOLcarisoprodoltablet70820155.9%7.7%-0.7%60.8%147.3%
ANDA202315  CALCIUM ACETATEcalcium acetatecapsule62920157.0%7.0%-3.5%57.4%143.9%
ANDA202885  CALCIUM ACETATEcalcium acetatetablet12220157.6%12.1%11.5%73.3%174.4%
ANDA204279  HYDROXYZINE HYDROCHLORIDEhydroxyzine hydrochloridetablet82020146.2%2.2%12.0%17.7%173.1%
ANDA202150  MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEhydrochlorothiazidetablet3072014-10.5%-7.8%-8.4%3.6%148.9%
ANDA202436  TRANEXAMIC ACIDtranexamic acidinjectable2112014-5.5%-4.9%0.7%4.7%169.5%
ANDA091431  AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDEamlodipine besylatecapsule12302013-0.5%-5.0%7.6%17.5%166.2%
ANDA201964  FELODIPINEfelodipinetablet, extended release110820130.1%-2.5%9.6%27.0%176.2%
ANDA201507  HYDROXYZINE PAMOATEhydroxyzine pamoatecapsule60320137.5%21.2%13.1%29.4%225.0%
ANDA200856  DOXYCYCLINE HYCLATEdoxycycline hyclatetablet, delayed release430201315.0%19.1%19.6%28.3%233.4%
ANDA202644  NIFEDIPINEnifedipinecapsule425201317.6%20.5%20.8%33.2%238.3%
ANDA201336  FLUOXETINE HYDROCHLORIDEfluoxetine hydrochloridecapsule10012012-0.3%-4.2%8.6%11.9%217.5%
ANDA200892  ETHOSUXIMIDEethosuximidecapsule9252012-0.5%1.7%15.6%17.2%226.3%
ANDA202845  DIFLUNISALdiflunisaltablet30820127.9%13.2%17.8%55.0%285.9%
ANDA091605  DOXYCYCLINEdoxycyclinetablet122020116.5%9.7%17.7%39.2%283.0%
ANDA077344  DONEPEZIL HYDROCHLORIDEdonepezil hydrochloridetablet5312011-11.1%-11.8%4.8%15.7%278.7%
ANDA200502  NARATRIPTANnaratriptan hydrochloridetablet2282011-10.8%-19.4%-3.7%4.2%243.5%
ANDA090937  GLYBURIDEglyburidetablet2282011-10.8%-19.4%-3.7%4.2%243.5%
ANDA091254  PRAMIPEXOLE DIHYDROCHLORIDEpramipexole dihydrochloridetablet113020108.7%-1.1%-7.2%13.3%274.5%
ANDA078551  PRAMIPEXOLE DIHYDROCHLORIDEpramipexole dihydrochloridetablet10082010-6.1%-1.0%-21.2%7.9%249.8%
ANDA090402  TACROLIMUStacrolimuscapsule7012010-6.0%-6.3%-13.0%2.6%245.1%
ANDA078728  GLIPIZIDE AND METFORMIN HYDROCHLORIDEglipizidetablet6232010-6.1%-5.6%-11.4%2.1%254.6%
ANDA091256  BETHANECHOL CHLORIDEbethanechol chloridetablet50420102.9%-7.0%-8.0%-9.7%241.4%
ANDA078879  TEMOZOLOMIDEtemozolomidecapsule30120100.8%-15.4%0.4%-6.5%246.0%
ANDA040858  HYDRALAZINE HYDROCHLORIDEhydralazine hydrochloridetablet22620101.2%-12.3%1.4%-3.3%247.4%
ANDA077585  GALANTAMINE HYDROBROMIDEgalantamine hydrobromidetablet915200911.1%21.0%6.7%-4.9%312.7%
ANDA079009  GLYBURIDE AND METFORMIN HYDROCHLORIDEglyburidetablet6032009-1.2%2.7%20.0%2.5%311.7%
ANDA078554  VENLAFAXINE HYDROCHLORIDEvenlafaxine hydrochloridetablet1092009-3.0%-10.0%19.3%16.4%333.6%
ANDA040904  ACETAZOLAMIDEacetazolamidecapsule, extended release12102008-20.2%-0.5%6.4%9.8%323.0%
ANDA078489  ALPRAZOLAMalprazolamtablet, extended release10172008-16.6%-17.8%-2.8%7.0%267.7%
ANDA077769  RISPERIDONErisperidonetablet10162008-7.6%-14.4%1.3%11.5%283.2%
ANDA076228  RISPERIDONErisperidonetablet6302008-21.6%-23.5%-24.4%-2.1%235.9%
ANDA077724  PRAMIPEXOLE DIHYDROCHLORIDEpramipexole dihydrochloridetablet2192008-14.7%-26.5%-39.0%-24.3%171.0%
ANDA078615  CETIRIZINE HYDROCHLORIDE ALLERGYcetirizine hydrochloridetablet12282007-12.4%-18.5%-36.9%-27.9%172.6%
ANDA040734  METHIMAZOLEmethimazoletablet12142007-9.8%-15.0%-40.1%-30.2%161.8%
ANDA065173  PAROMOMYCIN SULFATEparomomycin sulfatecapsule12142007-9.8%-15.0%-40.1%-30.2%161.8%
ANDA040682  BENZONATATEbenzonatatecapsule7302007-4.8%-20.5%-37.9%-44.4%131.7%
ANDA076377  TERBINAFINE HYDROCHLORIDEterbinafine hydrochloridetablet7022007-6.4%-15.4%-36.0%-48.3%131.8%
ANDA077811  NIMODIPINEnimodipinecapsule50220072.9%-5.2%-14.2%-48.9%140.3%
ANDA077345  SERTRALINE HYDROCHLORIDEsertraline hydrochloridetablet2062007-5.3%-5.4%-16.5%-46.8%127.6%
ANDA077663  SERTRALINE HYDROCHLORIDEsertraline hydrochloridetablet2062007-5.3%-5.4%-16.5%-46.8%127.6%
ANDA077299  SERTRALINE HYDROCHLORIDEsertraline hydrochloridetablet2062007-5.3%-5.4%-16.5%-46.8%127.6%
ANDA076465  SERTRALINE HYDROCHLORIDEsertraline hydrochloridetablet8112006-4.9%-4.7%-9.3%-42.0%113.4%
ANDA077213  CITALOPRAM HYDROBROMIDEcitalopram hydrobromidetablet3312006-8.5%-8.9%-11.2%-36.0%99.1%

Financials

Segment Financials

Revenue by Segment
$ Mil20252024202320222021
Commercial banking246217244249240
Total246217244249240


Price Behavior

Price Behavior
Market Price$29.73 
Market Cap ($ Bil)1.2 
First Trading Date05/07/1998 
Distance from 52W High-4.9% 
   50 Days200 Days
DMA Price$28.88$25.96
DMA Trendupup
Distance from DMA2.9%14.5%
 3M1YR
Volatility23.6%28.1%
Downside Capture23.0156.01
Upside Capture56.0981.10
Correlation (SPY)9.3%31.1%
HFWA Betas & Captures as of 7/31/2026

 1M2M3M6M1Y3Y
Beta0.13-0.020.160.440.680.77
Up Beta-0.04-0.71-0.190.310.920.82
Down Beta-0.09-0.19-0.170.150.400.73
Up Capture29%54%54%66%74%55%
Bmk +ve Days11223567138427
Stock +ve Days11263669128386
Down Capture24%-3%25%49%65%90%
Bmk -ve Days11212859114326
Stock -ve Days11172755121359

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with HFWA
HFWA36.2%28.1%1.08-
Sector ETF (XLF)9.4%14.8%0.3955.0%
Equity (SPY)18.8%12.9%1.0731.0%
Gold (GLD)23.6%28.1%0.74-4.1%
Commodities (DBC)30.2%19.7%1.22-20.7%
Real Estate (VNQ)13.7%13.9%0.6938.7%
Bitcoin (BTCUSD)-44.8%42.9%-1.2612.9%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with HFWA
HFWA9.8%31.0%0.34-
Sector ETF (XLF)11.3%18.4%0.4758.5%
Equity (SPY)12.6%17.1%0.5639.1%
Gold (GLD)17.1%18.5%0.75-3.8%
Commodities (DBC)9.0%19.5%0.353.9%
Real Estate (VNQ)2.5%18.9%0.0342.0%
Bitcoin (BTCUSD)14.2%53.3%0.4514.2%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with HFWA
HFWA9.4%32.9%0.35-
Sector ETF (XLF)13.6%22.0%0.5668.1%
Equity (SPY)15.0%17.9%0.7149.0%
Gold (GLD)11.3%16.1%0.57-7.6%
Commodities (DBC)7.3%18.0%0.3213.6%
Real Estate (VNQ)4.9%20.7%0.2046.7%
Bitcoin (BTCUSD)58.2%66.2%0.9810.4%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date7152026
Short Interest: Shares Quantity2.6 Mil
Short Interest: % Change Since 6302026-0.5%
Average Daily Volume0.3 Mil
Days-to-Cover Short Interest9.1 days
Basic Shares Quantity38.7 Mil
Short % of Basic Shares6.7%

Earnings Returns History

Updated 8/1/2026
Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
7/23/2026-0.4%-2.4% 
4/23/2026-4.4%-0.6%-1.0%
1/22/2026-5.5%-8.6%-2.8%
10/23/20250.3%-2.6%2.0%
7/24/20250.8%-3.1%6.1%
4/24/2025-1.7%0.2%1.5%
1/23/2025-0.8%2.9%-1.9%
10/24/2024-0.1%2.8%19.7%
...
SUMMARY STATS   
# Positive61114
# Negative17128
Median Positive0.7%2.9%6.0%
Median Negative-1.2%-3.7%-2.3%
Max Positive5.7%6.6%19.7%
Max Negative-5.5%-13.0%-17.8%
Collapse to Preview
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
7/23/2026-0.4%-2.4% 
4/23/2026-4.4%-0.6%-1.0%
1/22/2026-5.5%-8.6%-2.8%
10/23/20250.3%-2.6%2.0%
7/24/20250.8%-3.1%6.1%
4/24/2025-1.7%0.2%1.5%
1/23/2025-0.8%2.9%-1.9%
10/24/2024-0.1%2.8%19.7%
7/25/20240.6%-1.0%1.2%
4/26/2024-1.2%5.7%1.9%
1/29/2024-2.0%-10.3%-10.9%
10/19/2023-3.8%-5.9%3.5%
7/20/2023-4.8%0.2%-1.7%
4/20/2023-0.1%-13.0%-17.8%
1/27/2023-1.2%5.6%-0.8%
10/20/20220.6%3.4%6.6%
7/21/2022-1.4%1.0%5.9%
4/21/2022-1.7%-4.4%-6.1%
1/27/2022-0.0%2.8%9.3%
10/22/2021-1.2%-2.2%0.9%
7/23/20212.2%6.3%10.6%
4/22/20215.7%6.6%9.5%
10/22/2020-1.0%-5.0%11.4%
SUMMARY STATS   
# Positive61114
# Negative17128
Median Positive0.7%2.9%6.0%
Median Negative-1.2%-3.7%-2.3%
Max Positive5.7%6.6%19.7%
Max Negative-5.5%-13.0%-17.8%

SEC Filings

Expand for More
Report DateFiling DateFiling
03/31/202605/08/202610-Q
12/31/202502/27/202610-K
09/30/202511/07/202510-Q
06/30/202508/08/202510-Q
03/31/202505/06/202510-Q
12/31/202402/27/202510-K
09/30/202411/06/202410-Q
06/30/202408/09/202410-Q
03/31/202405/07/202410-Q
12/31/202302/27/202410-K
09/30/202311/09/202310-Q
06/30/202308/04/202310-Q
03/31/202305/04/202310-Q
12/31/202202/24/202310-K
09/30/202211/09/202210-Q
06/30/202208/09/202210-Q
Collapse to Preview
Report DateFiling DateFiling
03/31/202605/08/202610-Q
12/31/202502/27/202610-K
09/30/202511/07/202510-Q
06/30/202508/08/202510-Q
03/31/202505/06/202510-Q
12/31/202402/27/202510-K
09/30/202411/06/202410-Q
06/30/202408/09/202410-Q
03/31/202405/07/202410-Q
12/31/202302/27/202410-K
09/30/202311/09/202310-Q
06/30/202308/04/202310-Q
03/31/202305/04/202310-Q
12/31/202202/24/202310-K
09/30/202211/09/202210-Q
06/30/202208/09/202210-Q
03/31/202205/04/202210-Q
12/31/202102/25/202210-K
09/30/202111/08/202110-Q
06/30/202108/05/202110-Q
03/31/202105/05/202110-Q
12/31/202002/26/202110-K
09/30/202011/09/202010-Q
06/30/202008/05/202010-Q
03/31/202005/05/202010-Q
12/31/201902/28/202010-K
09/30/201911/06/201910-Q
06/30/201908/08/201910-Q

Insider Activity

Updated 7/30/2026
Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Wilson, Kelli AnnEVP Chief Banking OfficerDirectSell730202629.693,778112,17892,017Form
2Hinson, DonaldEVPand Chief Financial OfficerDirectSell610202628.373,842109,0131,170,168Form
3Robison, Sabrina CEVP Chief HR OfficerDirectSell504202627.5171619,697905,932Form
4Robison, Sabrina CEVP Chief HR Officer401(K) PlanSell504202627.614,724  Form
5Chalfant, TonyEVP Chief Credit OfficerDirectSell211202627.654,668129,065549,382Form
Collapse to Preview
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Wilson, Kelli AnnEVP Chief Banking OfficerDirectSell730202629.693,778112,17892,017Form
2Hinson, DonaldEVPand Chief Financial OfficerDirectSell610202628.373,842109,0131,170,168Form
3Robison, Sabrina CEVP Chief HR OfficerDirectSell504202627.5171619,697905,932Form
4Robison, Sabrina CEVP Chief HR Officer401(K) PlanSell504202627.614,724  Form
5Chalfant, TonyEVP Chief Credit OfficerDirectSell211202627.654,668129,065549,382Form
6Rivera, Frederick B DirectSell203202626.311,80047,350130,790Form
7Wilson, Kelli AnnEVP Chief Banking OfficerDirectSell126202626.481,90050,307100,032Form
8McDonald, BryanPresident401(K) PlanBuy1124202522.3219,106426,446700,022Form

Investor Activity (13F)

Updated Aug 1, 2026
13F holdings as of Mar 31, 2026 (Q1 2026)

Active managers (13F portfolio over $250M, at least 3 holdings) with a position over $5M that is either over 10% of their portfolio or held in a concentrated book of 50 or fewer total positions. Index/ETF, sovereign, bank, community-bank and charitable/donor-advised filers are excluded.

Active ManagerValue% of PortfolioTotal PositionsQoQFiling
Rhino Investment Partners, Inc$8.6 Mil2.4%39ADD +77.7%13F
Active ManagerValue% of PortfolioTotal PositionsQoQFiling
Rhino Investment Partners, Inc$8.6 Mil2.4%39ADD +77.7%13F
Active Manager
Active ManagerValue% of PortfolioTotal PositionsQoQFiling
Rhino Investment Partners, Inc$8.6 Mil2.4%39ADD +77.7%13F
Core Cache Last Updated: 7/31/2026